CIK 0001598646
- Non-accelerated filer
- Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 260784194
- Phone
- +1 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-11 | Reilly Joseph H. SVP & Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2018-12-11 | Race Geoff EVP, CFO & CBO | Grant or award · Employee Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2018-12-11 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +410,000 | 410,000 | ||
| 2018-12-11 | Davidson Michael Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2018-12-11 | Ahlholm Frederick W SVP, Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2018-12-11 | DOYLE WILLIAM F Director | Purchase | +4,000 | $7.95 | $32K | 20,611 |
| 2018-12-10 | DOYLE WILLIAM F Director | Purchase | +2,000 | $8.00 | $16K | 16,611 |
| 2018-11-20 | DOYLE WILLIAM F Director | Purchase | +2,000 | $8.20 | $16K | 14,611 |
| 2018-10-11 | DOYLE WILLIAM F Director | Purchase | +600 | $10.00 | $6K | 12,611 |
| 2018-10-01 | Reilly Joseph H. SVP & Chief Operating Officer | Option exercise | +15,000 | $4.71 | $71K | 29,177 |
| 2018-10-01 | Reilly Joseph H. SVP & Chief Operating Officer | Option exercise | +10,000 | $5.19 | $52K | 39,177 |
| 2018-10-01 | Reilly Joseph H. SVP & Chief Operating Officer | Sale | −23,300 | $12.02 | $280K | 15,877 |
| 2018-10-01 | Reilly Joseph H. SVP & Chief Operating Officer | Sale | −1,700 | $12.62 | $21K | 14,177 |
| 2018-10-01 | Reilly Joseph H. SVP & Chief Operating Officer | Option exercise · Employee Stock Option (Right to Buy) | −15,000 | 27,400 | ||
| 2018-10-01 | Reilly Joseph H. SVP & Chief Operating Officer | Option exercise · Employee Stock Option (Right to Buy) | −10,000 | 47,524 | ||
| 2018-10-01 | Index Venture Associates III Ltd 10% owner | Sale | −15,444 | $12.35 | $191K | 4,609,189 |
| 2018-09-28 | Index Venture Associates III Ltd 10% owner | Sale | −34,589 | $12.62 | $436K | 4,624,633 |
| 2018-09-27 | Index Venture Associates III Ltd 10% owner | Sale | −31,684 | $12.57 | $398K | 4,659,222 |
| 2018-09-17 | DOYLE WILLIAM F Director | Purchase | +1,800 | $10.50 | $19K | 12,011 |
| 2018-09-14 | DOYLE WILLIAM F Director | Purchase | +200 | $10.50 | $2K | 10,211 |
Page 9 of 16 · 305 trades